Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

56 results about "Streptomyces diastatochromogenes" patented technology

Streptomyces diastatochromogenes is a bacterium species from the genus of Streptomyces. Streptomyces diastatochromogenes produces polyketomycin, concanamycin A, concanamycin B, concanamycin C, momofulvenone A, azdimycin, toyocamycin and oligomycins.

Recombinant streptomyces diastatochromogenes with reinforced adpA expression, construction method and application

ActiveCN103233018AIncrease productionImproved ability to synthesize toyocamycinBacteriaMicroorganism based processesAmylaseEnzyme Gene
The invention discloses a recombinant streptomyces diastatochromogenes with reinforced adpA expression, a construction method and an application. A transcriptional regulation factor adpA at a secondary metabolism network center is excessively expressed, and the recombinant streptomyces diastatochromogenes has higher toyocamycin synthesis capacity compared with streptomyces diastatochromogenes 1628. The construction method comprises the following construction processes: (1) constructing an expression vector pIB139-adpA; and 2) merging the expression vector into a chromosome of the streptomyces diastatochromogenes by a conjugal transfer method so as to obtain engineering bacteria. The expression of adpA gene is started by utilizing a promoter permE* on the pIB139 vector, and the vector pIB139-adpA is specifically merged into the chromosome of the streptomyces diastatochromogenes 1628 by the conjugal transfer method so as to obtain the engineering bacteria with genetic stability. Compared with the original strain, the recombinant streptomyces diastatochromogenes has the advantages that the transcriptional level of a key enzyme gene toyF in the synthetic route of recombinant bacteria toyocamycin is obviously strengthened, and the yield of toyocamycin is improved by at least 31.6%. A foundation is laid for further improving the yield of toyocamycin and realizing industrial production as soon as possible.
Owner:CHINA JILIANG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products